Enhanced Chemosensitivity by Targeting Nanog in Head and Neck Squamous Cell Carcinomas

miR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor-Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer

(2013) C.-C. Yu et al.   CANCER RESEARCH

Autochthonous Mouse Melanoma and Mammary Tumors do not Express the Pluripotency Genes Oct4 and Nanog

(2013) Caroline Schreiber et al.   PLoS One

Localization of the stem cell markers LGR5 and Nanog in the normal and the cancerous human ovary and their inter-relationship

(2012) Abraham Amsterdam et al.   ACTA HISTOCHEMICA

Nanog: A Potential Biomarker for Liver Metastasis of Colorectal Cancer

(2012) Feng Xu et al.   DIGESTIVE DISEASES AND SCIENCES

Quercetin in elimination of tumor initiating stem-like and mesenchymal transformation property in head and neck cancer

(2012) Wen-Wei Chang et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Prognostic Impact of the Cancer Stem Cell–Related Marker NANOG in Ovarian Serous Carcinoma

(2012) Maria Lee et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers

(2012) M K Y Siu et al.   ONCOGENE

Enhancement of cancer stem-like and epithelial−mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: Reversal by targeting SNAIL

(2012) Cheng-Chia Yu et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Prognostic significance of NANOG and KLF4 for breast cancer

(2012) Takuya Nagata et al.   Breast Cancer

CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study

(2012) AINA HE et al.   Experimental and Therapeutic Medicine

Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain

(2011) T. W. Theunissen et al.   DEVELOPMENT

Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas

(2011) Yuji Guo et al.   HISTOPATHOLOGY

Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis

(2011) A. J. M. Gillis et al.   INTERNATIONAL JOURNAL OF ANDROLOGY

Expression of the Stem Cell Marker, Nanog, in Human Endometrial Adenocarcinoma

(2011) Xi Zhou et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma

(2011) Lo-Lin Tsai et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma

(2011) Ting Lin et al.   MEDICAL ONCOLOGY

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

(2011) Can Liu et al.   NATURE MEDICINE

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation

(2011) C R Jeter et al.   ONCOGENE

Nanog Is Highly Expressed in Ovarian Serous Cystadenocarcinoma and Correlated with Clinical Stage and Pathological Grade

(2011) Yongmiao Pan et al.   PATHOBIOLOGY

Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer

(2010) Hui-Min Meng et al.   CANCER BIOLOGY & THERAPY

Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell-Like Properties and Epithelial-Mesenchymal Transdifferentiation

(2010) S.-H. Chiou et al.   CANCER RESEARCH

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway

(2010) Xiao Qi Wang et al.   HEPATOLOGY

miR-200a Regulates Epithelial-Mesenchymal to Stem-like Transition via ZEB2 and β-Catenin Signaling

(2010) Hongping Xia et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells

(2010) Wen-Liang Lo et al.   JOURNAL OF PATHOLOGY

Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling

(2010) Meng-Ju Wu et al.   Molecular Cancer

Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells

(2010) Dimitrios Iliopoulos et al.   MOLECULAR CELL

Oct4 and Nanog Expression Is Associated With Early Stages of Pancreatic Carcinogenesis

(2010) Jing Wen et al.   PANCREAS

Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties

(2010) Elaine Lai-Han Leung et al.   PLoS One

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

(2009) Junfang Ji et al.   HEPATOLOGY

MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma

(2009) Livia Garzia et al.   PLoS One

MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells

(2009) Qing Ji et al.   PLoS One

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

(2008) Joachim Silber et al.   BMC Medicine

Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma

(2008) S.-H. Chiou et al.   CLINICAL CANCER RESEARCH